← back to search

Xiaolong Chen

National Sun Yat-sen University · TW
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Hepatocellular Carcinoma Treatment and Prognosis.
h-index
29
citations
3,981
works
151
NIH funding
primary concept
email

Recent publications

Photothermal-triggered NO-releasing nanofiber membrane mitigates intervertebral disc degeneration via inflammation inhibition and matrix stabilization
Materials Today Bio 2025cited by 1position: middledoi
Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study
Scientific Reports 2024cited by 13position: middledoi
JNK signaling mediates acute rejection via activating autophagy of CD8+ T cells after liver transplantation in rats
Frontiers in Immunology 2024cited by 3position: middledoi
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Nature Communications 2023cited by 147position: middledoi
Hippo (YAP)–autophagy axis protects against hepatic ischemia-reperfusion injury through JNK signaling
Chinese Medical Journal 2023cited by 26position: middledoi
Prognostic value of index of cardiac electrophysiological balance among US middle-aged adults
Frontiers in Cardiovascular Medicine 2023cited by 9position: firstdoi
Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding
Langenbeck s Archives of Surgery 2023cited by 5position: middledoi
Puerarin attenuates cisplatin-induced apoptosis of hair cells through the mitochondrial apoptotic pathway
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022cited by 26position: middledoi
E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
Cell Death and Disease 2020cited by 76position: middledoi
RETRACTED ARTICLE: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer
Molecular Cancer 2019cited by 438position: middledoi
CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma
Cancer Medicine 2019cited by 31position: middledoi
High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.
PubMed 2019cited by 16position: last
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Gut 2018cited by 789position: middledoi
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion
Journal for ImmunoTherapy of Cancer 2018cited by 299position: middledoi
MiR‐139‐5p is associated with poor prognosis and regulates glycolysis by repressing <scp>PKM</scp> 2 in gallbladder carcinoma
Cell Proliferation 2018cited by 77position: middledoi
Association Between Complement Factor <i>C2/C3/CFB/CFH</i> Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis
Genetic Testing and Molecular Biomarkers 2018cited by 29position: middledoi
Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis
Hepatobiliary & pancreatic diseases international 2018cited by 19position: middledoi
Haoranjiania flava gen. nov., sp. nov., a new member of the family Chitinophagaceae, isolated from activated sludge
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 2016cited by 20position: middledoi
Devosia honganensis sp. nov., isolated from the soil of a chemical factory
Antonie van Leeuwenhoek 2015cited by 16position: middledoi
Study of amphotericin B magnetic liposomes for brain targeting
International Journal of Pharmaceutics 2014cited by 29position: middledoi
Crosstalk between dopamine receptors and the Na+/K+-ATPase (Review)
Molecular Medicine Reports 2013cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Genshu Wang · Guangzhou University of Chinese Medicine5 papers (2018–2024)Guangying Cui · China University of Geosciences (Beijing)5 papers (2018–2020)Yan Yu · Sun Yat-sen University Cancer Center4 papers (2018–2020)Wenfeng Zhu · Tongji University4 papers (2023–2024)Zhigang Ren · Shandong University4 papers (2018–2019)Ranran Sun · Anhui Medical University4 papers (2018–2019)Kongfei Li · Ningbo University4 papers (2018–2020)Haoqi Chen · Qingdao University4 papers (2023–2024)Juan Li · Northwest University3 papers (2018–2019)Xiaowen Wang · Harvard University Press3 papers (2023–2024)Shuguang Zhu · Institute for Advanced Study3 papers (2023–2024)Zibin Gao · Hebei University of Science and Technology2 papers (2013–2014)Jianan Chen · Shandong University2 papers (2018–2019) · 2 papers (2018–2019)Yuting He · Fudan University2 papers (2018–2019)Yongjun Sun · East China Jiaotong University2 papers (2013–2014)Shunpeng Li · South China Agricultural University2 papers (2015–2016)Kai Chen · Nanjing Agricultural University2 papers (2015–2016)Chen Xue · Shanghai Medical College of Fudan University2 papers (2018–2019)Jiandong Jiang · Nanjing Agricultural University2 papers (2015–2016)